Study at a glance
What question did the studies ask?
Does vitamin D change immune ageing or persistent inflammation in older adults, and do those changes improve immune function? Studies measured cells, skin responses, vaccine antibodies and blood markers. Some experiments used cultured cells.
What did they find?
Selected cell-ageing markers decreased, and a local skin response improved. Other trials did not establish better measured immune function or vaccine responses. A VITAL analysis found a reduction in one inflammation marker at two years, but not four years. Several other markers did not improve.
What does this mean?
A laboratory change does not establish that the immune system becomes younger. A study needs to show that the change leads to meaningful improvement in function.
What are the limits?
Several studies were small or short. One clinical cohort appeared in two papers and is not two independent confirmations. Different populations and measurements limit comparison. These findings do not establish immune rejuvenation or an anti-ageing treatment.
Read the full article below ↓Studies do not establish that taking extra vitamin D makes an older person’s immune system younger. Some studies found changes in selected cell measurements or a local skin response. Other trials did not find better immune function or a consistent reduction in inflammation. A laboratory change and a health benefit are different outcomes. Read the detailed review, Vitamin D, Immune Ageing and the Gap Between Markers and Function: Full Evidence Review.
What was studied?
Researchers studied older adults with different health and vitamin D backgrounds. They measured immune-cell types, cell-ageing markers, responses to vaccination and inflammatory proteins in blood. Some experiments used cultured cells rather than people. These differences matter when applying a result to the people described in Vitamin D in Older Adults.
What changed?
An uncontrolled study followed 18 older adults during vitamin D replacement. The overall skin response to an antigen improved, but participants differed. An antigen is a substance recognised by the immune system. Without a randomised comparison group, the study could not establish that vitamin D caused the improvement. It did not prove protection from shingles or improvement throughout the body.
A related laboratory paper tested calcitriol, the active vitamin D hormone, in tissue cells. It found changes in selected inflammatory signals. Its human analysis reused the same 18 people, so it was not a second independent clinical confirmation.
A trial in 88 older adults found changes in some cell-ageing measurements under different vitamin D regimens, with or without N-acetylcysteine, a separate supplement. It did not demonstrate corresponding benefits in several blood inflammation markers or clinical immune protection. Its published correction must also be applied: a dose label was 5,000 international units, not 50,000 international units. These were research regimens, not personal instructions.
What did not show a clear benefit?
A small 12-week trial raised vitamin D concentrations without demonstrating better measured immune function. A separate influenza-vaccine trial in 38 older adults with low vitamin D did not establish an overall antibody benefit. The broader recall question is introduced in Vitamin D and Immune Memory. Recall means the response to something the immune system has encountered before.
In a one-year trial in older adults, most inflammatory markers did not clearly improve. A VITAL analysis found a reduction in one inflammation marker at two years, but not at four years. Several other markers did not improve. The study did not show that the temporary change caused better protection against infection.
Why are these distinctions important?
Immune ageing is not one blood test. A different mixture of cells does not automatically mean better or worse protection. In one small observational study, higher vitamin D was associated with fewer naïve T cells, which have not yet acquired antigen experience, and more effector T cells, which carry out immune responses. This could not show that vitamin D caused ageing or improved immunity.
Persistent inflammation, discussed in Vitamin D and Chronic Inflammation, is related to immune ageing. But lowering one marker does not establish that the immune system works better. Studies need to demonstrate that connection. The evidence includes useful biological clues and important findings that did not show a benefit; it does not establish immune rejuvenation or a general anti-ageing benefit from supplementation.
Sources
Related reading
Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.
Original paper ↗Read more →Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial
This randomized placebo-controlled double-blind trial investigated whether Vit-D supplementation in deficient elderly persons could improve influenza seroprotection and immune response.
Original paper ↗Read more →Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing
Vitamin D3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity.
Original paper ↗Read more →Vitamin D3 replacement enhances antigen-specific immunity in older adults
We investigated the use of vitamin D3 replacement to enhance cutaneous antigen-specific immunity in older adults (≥65 years).
Original paper ↗Read more →Vitamin D, Immune Ageing and the Gap Between Markers and Function: Full Evidence Review
Evidence on vitamin D, immune-cell ageing, recall responses and inflammageing.
Read more →Vitamin D, Long-Term Inflammation, Biological Ageing and Metabolic Risk: Full Evidence Review
Review VITAL, DO-HEALTH and TILDA findings on vitamin D, inflammatory markers, biological ageing and metabolic risk, with causal limits explained.
Read more →What Immune-Ageing Measurements Can and Cannot Tell Us
A guide to immune-cell counts, senescence markers, inflammation tests and recall responses, and the different questions each measurement answers.
Read more →Vitamin D and Immune Ageing
Immune ageing involves gradual changes in immune function across the lifespan.
Read more →Effects of micronutrient supplementation on immune function in older adults: a meta-analysis
This systematic review and meta-analysis of randomized controlled trials (RCTs) evaluate the impact of micronutrient supplementation on immune function in older adults.
Original paper ↗Read more →Epidemiology of 40 blood biomarkers of one-carbon metabolism, vitamin status, inflammation, and renal and endothelial function among cancer-free older adults
Imbalances of blood biomarkers are associated with disease, and biomarkers may also vary non-pathologically across population groups.
Original paper ↗Read more →Immune risk phenotype and long-term mortality after community-acquired pneumonia in older adults: clinical and immune determinants
Community-acquired pneumonia (CAP) has been associated with poor long-term outcomes in older adults.
Original paper ↗Read more →Vitamin D Supplementation and Low-Grade Inflammation in Deficient Adults: Study Summary
Summary of a vitamin D trial in deficient adults: higher blood levels, no clear inflammatory improvement, and key limits of the 16-week findings.
Read more →Epidemiological characteristics, SAP-associated sepsis, and prognostic analysis of persistent inflammation: immunosuppression-catabolism syndrome in severe acute pancreatitis patients after percutaneous drainage: a retrospective study
Multivariate logistic regression with sepsis as a covariate identified independent PICS risk factors; Kaplan: Meier and Cox regression evaluated prognostic impact.
Original paper ↗Read more →Frailty in Older Adults with Severe Aortic Stenosis: The Role of Systemic Inflammation and Calcium Homeostasis
This study aimed to analyze systemic inflammation and calcium homeostasis biomarkers and their associations with frailty in older adults with severe AoS.
Original paper ↗Read more →Investigation of the Relationship Between Glycemic Control and Inflammation-Nutrition Indices in Older Adults with Type 2 Diabetes
Objective: To investigate the relationship between glycemic control and inflammation: nutrition indices in older adults with type 2 diabetes mellitus and to evaluate their prognostic value for 30-day mortality.
Original paper ↗Read more →Persistent inflammation during anti-tuberculosis treatment with diabetes comorbidity
The analysis compared 17 markers of inflammation in tuberculosis patients with and without diabetes at diagnosis, and at two time periods during the 6-month course of treatment.
Original paper ↗Read more →The serum vitamin D levels alleviate the influence of dietary inflammation on frailty: A cross-sectional analysis in the U.S. older adults
The current study aimed to explore the mediating association of vitamin D levels in the link between DI and frailty.
Original paper ↗Read more →Thirteen weeks of supplementation of vitamin D and leucine-enriched whey protein nutritional supplement attenuates chronic low-grade inflammation in sarcopenic older adults: the PROVIDE study
A chronic low-grade inflammatory profile (CLIP) is associated with sarcopenia in older adults.
Original paper ↗Read more →Vitamin D status & associations with inflammation in older adults
We aimed to investigate the association of C-reactive protein (CRP) with vitamin D status in a representative sample of the older Irish population.
Original paper ↗Read more →Vitamin D Deficiency in Institutionalized Older Adults: Associations with Supplementation Practices but Not with Cognitive Decline or Dementia
Background/Objectives: Population aging has been accompanied by increased institutionalization of older adults and a high prevalence of vitamin D deficiency in this group.
Original paper ↗Read more →Vitamin D Deficient Older Adults Are More Prone to Have Metabolic Syndrome, but Not to a Greater Number of Metabolic Syndrome Parameters
This study investigated the relationship between metabolic parameters and low serum 25-hydroxyvitamin D (25(OH)D) levels in older adults (n = 265).
Original paper ↗Read more →Original sources
Vitamin D3 replacement enhances antigen-specific immunity in older adults
We investigated the use of vitamin D3 replacement to enhance cutaneous antigen-specific immunity in older adults (≥65 years).
Publication details
Chambers et al. (2021). Vitamin D3 replacement enhances antigen-specific immunity in older adults. Immunotherapy Advances. 1(1):ltaa008. DOI: 10.1093/immadv/ltaa008.
Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing
Vitamin D3 replacement in older insufficient adults significantly improves their antigen‐specific varicella zoster virus (VZV) cutaneous immunity.
Publication details
Sayegh et al. (2024). Vitamin D3 inhibits p38 MAPK and senescence‐associated inflammatory mediator secretion by senescent fibroblasts that impacts immune responses during ageing. Aging Cell. 23(4):e14093. DOI: 10.1111/acel.14093.
Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial
Published in Frontiers in Immunology. 16:1570441. DOI: 10.3389/fimmu (2025).
Publication details
Rastgoo et al. (2025). Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Frontiers in Immunology. 16:1570441. DOI: 10.3389/fimmu.2025.1570441.
Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial
Published in Frontiers in Immunology. 16:1627178. Correction. DOI: 10.3389/fimmu (2025).
Publication details
Rastgoo et al. (2025). Corrigendum: Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial. Frontiers in Immunology. 16:1627178. Correction. DOI: 10.3389/fimmu.2025.1627178.
Influence of vitamin D supplementation on immune function of healthy aging people: A pilot randomized controlled trial
Published in Frontiers in Nutrition. 9:1005786. DOI: 10.3389/fnut (2022).
Publication details
Dong et al. (2022). Influence of vitamin D supplementation on immune function of healthy aging people: A pilot randomized controlled trial. Frontiers in Nutrition. 9:1005786. DOI: 10.3389/fnut.2022.1005786.
Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging
Published in Advances in aging research. 2(2):72-80. DOI: 10.4236/aar (2013).
Publication details
Hwang et al. (2013). Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging. Advances in aging research. 2(2):72-80. DOI: 10.4236/aar.2013.22010.
Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial
This randomized placebo-controlled double-blind trial investigated whether Vit-D supplementation in deficient elderly persons could improve influenza seroprotection and immune response.
Publication details
Gonçalves-Mendes et al. (2019). Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial. Frontiers in Immunology. 10:65. DOI: 10.3389/fimmu.2019.00065.
Effect of vitamin D supplementation on selected inflammatory biomarkers in older adults: a secondary analysis of data from a randomised, placebo-controlled trial
Waterhouse et al. (2015).
Publication details
Waterhouse et al. (2015). Effect of vitamin D supplementation on selected inflammatory biomarkers in older adults: a secondary analysis of data from a randomised, placebo-controlled trial. The British journal of nutrition. 114(5):693-699. DOI: 10.1017/S0007114515002366.
Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial
Background: The VITAL study was a nationwide, randomized, double-blind, placebo-controlled, 2 × 2 factorial trial of vitamin D3 (2000 IU/day) and marine n-3 FAs (1 g/day) supplements.
Publication details
Dong et al. (2022). Effects of Vitamin D3 and Marine Omega-3 Fatty Acids Supplementation on Biomarkers of Systemic Inflammation: 4-Year Findings from the VITAL Randomized Trial. Nutrients. 14(24):5307. DOI: 10.3390/nu14245307.